金色化物Rk1通过内分泌网膜信号通路抑制HeLa细胞的增殖
Qiuyang Li1, Hang Sun1, Shiwei Liu1
1College of Food Science and Engineering, Jilin Agricultural University, Changchun, China.
Journal of ginseng research
|September 18, 2023
概括
金色化物Rk1通过阻断细胞分裂和促进细胞亡来抑制宫癌HeLa细胞的增殖. 这种天然化合物通过向内质网膜蛋白质合成,特别是YOD1.1,显示出治疗宫癌的潜力.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学 是一个学科.
- 细胞生物学 细胞生物学
背景情况:
- 年轻人群中宫癌发病率上升与工作与生活平衡的变化有关.
- 生素Rk1是一种人参的素,对各种人类癌细胞具有抗癌作用.
- 辛斯化物Rk1对HeLa宫癌细胞增殖的影响仍然未被探索.
研究的目的:
- 为了研究金氏化物Rk1对HeLa细胞增殖的抑制作用.
- 阐明人参化物Rk1对HeLa细胞作用的潜在分子机制.
主要方法:
- 治疗HeLa细胞时使用不同剂量的金氏化物Rk1.
- 分析了细胞周期进展,细胞亡,自和内细胞网膜蛋白质处理.
- 使用定量PCR和西式斑点测试来评估特定的基因和蛋白质表达水平 (YOD1,HSPA4L,DNAJC3,HSP90AA1).
主要成果:
- 银化物Rk1在G0/G1阶段引起了剂量依赖的细胞周期停止,抑制了增殖.
- 通过激活caspase 3,PARP和caspase 6来诱导亡.
- 促进了自信号通路 (增加了LC3B),而内网膜蛋白质处理被降低了.
- 显著减少了YOD1,HSPA4L,DNAJC3和HSP90AA1的表达,其中YOD1表现出最明显的抑制.
结论:
- 金色化物Rk1通过抑制内细胞网膜蛋白质合成和增强亡,对HeLa细胞产生毒性.
- 对YOD1的下调表明它有可能成为治疗宫癌治疗的治疗标.
相关概念视频
01:22PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
01:15Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:07MAPK Signaling Cascades
5.6K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.6K